Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 118Neoplasms 110Lung Neoplasms 65Colorectal Neoplasms 52Prostatic Neoplasms 46Carcinoma, Non-Small-Cell Lung 46Pancreatic Neoplasms 34Melanoma 33Ovarian Neoplasms 29Neoplastic Cells, Circulating 29Head and Neck Neoplasms 27Uterine Cervical Neoplasms 23Multiple Myeloma 20Glioma 20Colonic Neoplasms 20Sarcoma 19Carcinoma, Hepatocellular 19Leukemia, Myeloid, Acute 18Neoplasm Metastasis 17Lymphoma 15Glioblastoma 15Esophageal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Hematologic Neoplasms 14Leukemia 13Endometrial Neoplasms 13Myelodysplastic Syndromes 11Kidney Neoplasms 11Gastrointestinal Neoplasms 11Carcinoma, Renal Cell 11

Interventions

Nutrition Assessment 2Collagenases 2upadacitinib 1tocilizumab 1methyl hydroxyethyl cellulose 1acetaminophen, aspirin, caffeine drug combination 1Walking 1Vaccines 1Transcutaneous Electric Nerve Stimulation 1Saline Solution 1Resistance Training 1Radiotherapy 1Omeprazole 1Naproxen 1Melphalan 1Magnetic Resonance Spectroscopy 1Lysine Acetyltransferase 5 1Injections, Intra-Articular 1Infliximab 1Immune Checkpoint Inhibitors 1Holistic Health 1Herpes Zoster Vaccine 1Febuxostat 1Exergaming 1Exercise Therapy 1Etanercept 1Colchicine 1Cari-D-Tect 1Blood Specimen Collection 1Arthroplasty, Replacement, Shoulder 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Arthritis × Blood Specimen Collection × Clear all
NCT07284563 2025-12-16

Ultralow Dose PET Imaging for 18F-NaF Uptake

Nuclear Imaging Institute

Phase 2 Recruiting
200 enrolled

Arthritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡